MDA 19

Discontinued Product

4205 has been discontinued.

View all CB<sub>2</sub> Receptors products.
说明: CB2 agonist
化学名: N'-[(3Z)-1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene]benzohydrazide
纯度: ≥99% (HPLC)
说明书
引用文献
评论
文献 (1)

生物活性 for MDA 19

MDA 19 is a CB2 receptor agonist. Displays 4-fold higher affinity for the human CB2 receptor than the human CB1 receptor (Ki values are 43.3 and 162.4 nM respectively); shows 70-fold affinity for the rat CB2 receptor over the rat CB1 receptor (Ki values are 16.3 and 1130 nM respectively). Attenuates tactile allodynia in a rat model; does not affect rat locomotor activity.

技术数据 for MDA 19

分子量 349.43
公式 C21H23N3O2
储存 Store at +4°C
纯度 ≥99% (HPLC)
CAS Number 1048973-47-2
PubChem ID 25034599
InChI Key ZGQHMZCITJHYOW-QOCHGBHMSA-N
Smiles O=C(C3=CC=CC=C3)N\N=C(C1=CC=CC=C1N2CCCCCC)/C2=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

按标靶查看相关产品

按产品操作查看相关产品

查看全部 CB2 Receptor Agonists

关键词: MDA 19, MDA 19 supplier, MDA19, cb2, cannabinoid, agonists, CB2, Receptors, 4205, Tocris Bioscience

篇 MDA 19 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 MDA 19 的引用文献。

MDA 19 的评论

目前没有该产品的评论。 Be the first to review MDA 19 and earn rewards!

Have you used MDA 19?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Cannabinoid Receptor Ligands Scientific Review

Cannabinoid Receptor Ligands Scientific Review

Written by Roger Pertwee, this review discusses compounds which affect the activity of the endocannabinoid system, focusing particularly on ligands that are most widely used as experimental tools and denotes compounds available from Tocris.